← back to search

Xīn Gào

Qingdao University ·
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, and Cancer Immunotherapy and Biomarkers.
h-index
43
citations
8,285
works
292
NIH funding
primary concept
Medicine
email

Recent publications

Datopotamab deruxtecan (Dato-DXd) in locally advanced/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study.
Journal of Clinical Oncology 2025cited by 13position: middledoi
Prostate Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network 2024cited by 258position: middledoi
Bone‐Targeted Fluoropeptide Nanoparticle Inhibits NF‐κB Signaling to Treat Osteosarcoma and Tumor‐Induced Bone Destruction
Advanced Science 2024cited by 14position: middledoi
Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)
Cancer Research 2024cited by 9position: middledoi
Preconception depression reduces fertility: a couple-based prospective preconception cohort
Human Reproduction Open 2024cited by 9position: middledoi
A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study
Cell Reports Medicine 2023cited by 17position: middledoi
Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology 2022cited by 184position: firstdoi
DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases
Nature Communications 2022cited by 132position: middledoi
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts
Diabetologia 2022cited by 104position: middledoi
Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology 2022cited by 49position: middledoi
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
International Journal of Radiation Oncology*Biology*Physics 2022cited by 25position: middledoi
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
Nature Communications 2021cited by 163position: middledoi
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells
Molecular Cancer Therapeutics 2021cited by 79position: middledoi
Meta-analyses identify DNA methylation associated with kidney function and damage
Nature Communications 2021cited by 78position: middledoi
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
JAMA Network Open 2021cited by 39position: middledoi
Novel associations between inflammation-related proteins and adiposity: A targeted proteomics approach across four population-based studies
Translational research 2021cited by 37position: middledoi
DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function
Clinical Epigenetics 2021cited by 37position: middledoi
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
International Journal of Cardiology 2021cited by 35position: middledoi
Results of an ongoing phase 1/2a dose escalation study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager, in patients with metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology 2021cited by 34position: middledoi
Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study
EBioMedicine 2021cited by 31position: middledoi
Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus
Nature Communications 2021cited by 27position: middledoi
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
Frontiers in Genetics 2021cited by 20position: middledoi
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
Frontiers in Oncology 2021cited by 12position: middledoi
DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases
Research Square 2021cited by 12position: middledoi
Associations of Human Colorectal Adenoma with Serum Biomarkers of Body Iron Stores, Inflammation and Antioxidant Protein Thiols
Antioxidants 2021cited by 7position: middledoi
Genome-wide association study of mitochondrial copy number
Human Molecular Genetics 2021cited by 6position: middledoi
DNA Methylation-Based Estimates of Circulating Leukocyte Composition for Predicting Colorectal Cancer Survival: A Prospective Cohort Study
Cancers 2021cited by 5position: firstdoi
Relationship of Physical Activity at Older Age with Biomarkers of Oxidative Stress: A Large, Population-based Cohort Study
Medicine & Science in Sports & Exercise 2021cited by 4position: middledoi
Comparative Validation of Three DNA Methylation Algorithms of Ageing and a Frailty Index in Relation to Mortality: Results From the ESTHER Cohort Study
SSRN Electronic Journal 2021cited by 1position: middledoi
Identification of recessively inherited genetic variants for pancreatic cancer risk
Pancreatology 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hermann Brenner · Stanford University27 papers (2017–2021)Ben Schöttker · German Cancer Research Center26 papers (2017–2021)Xuan Yang · Zhejiang Chinese Medical University12 papers (2018–2020)Bernd Holleczek · Krebsregister Saarland11 papers (2018–2021)Ankita Anusruti · German Cancer Research Center10 papers (2018–2020)Eugène Jansen · National Institute for Public Health and the Environment10 papers (2018–2021)Yan Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College5 papers (2017–2021)Xiangwei Li · University of Nottingham Ningbo China4 papers (2020–2021)Jenny Chang‐Claude · Centre hospitalier universitaire de Québec4 papers (2020–2021)Michael Hoffmeister · Festo (Germany)4 papers (2020–2021)Hong Kuang · Harbin Medical University3 papers (2013–2014)Rana R. McKay · The Barbara Ann Karmanos Cancer Institute3 papers (2018–2022)Daniel Boakye · University of the West of Scotland3 papers (2020–2020)Xu Gao · Centre National de la Recherche Scientifique3 papers (2017–2019)Lina Jansen · Krebsregister Baden-Württemberg3 papers (2020–2021)David F. McDermott · Dana-Farber/Harvard Cancer Center2 papers (2018–2020) · 2 papers (2018–2019)Ning Shao · Shanghai Jiao Tong University2 papers (2013–2014)Kira Trares · German Cancer Research Center2 papers (2020–2021)Katarina Ćuk · BioNTech (Germany)2 papers (2018–2019)